Muluken Belew
About Muluken Belew
Title
Muluken Belew holds the position of Associate Director of Preclinical Translational Sciences. In this role, Muluken is involved in managing and overseeing preclinical research and translating scientific discoveries from the laboratory into potential clinical applications.
Education and Expertise
Muluken Belew earned a Ph.D. in Biochemistry and Biomedical Science from McMaster University. This advanced education provided Muluken with a strong foundation in biochemical processes and biomedical research, essential for his current role in preclinical research and translational sciences.
Professional Background
Before becoming the Associate Director of Preclinical Translational Sciences, Muluken Belew worked as a Principal Scientist at Novartis. In this capacity, he was responsible for leading discovery efforts using hematopoietic stem cells (HSCs). Muluken played a key role in enabling 'go/no-go' milestone decisions for partnered adeno-associated virus (AAV)-based in vivo gene editing strategies. This work was critical in advancing Novartis’ gene therapy projects.
Achievements at Novartis
At Novartis, Muluken Belew led discovery efforts that were pivotal for partnered AAV-based in vivo gene editing strategies. These efforts involved using hematopoietic stem cells (HSCs) to enable important 'go/no-go' milestone decisions, which were crucial in determining the viability of continued development for these gene-editing approaches.